- Company Directors - N
- Noble James
Insider Trading History of Noble James
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Noble James since 2007.
The trader's CIK number is 1388000.
At the time of the last reporting, Noble James was the Director of Adaptimmune Therapeutics Plc. (stock ticker symbol ADAP).
Also see all insider trading activities at Adaptimmune Therapeutics Plc.
Note that in the past
Noble James also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Adaptimmune Therapeutics Plc (ADAP) by Noble James
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2020 | ADAP | 0 | $0 | 800,000 | $6,016,000 | 0 | $0 |
2019 | ADAP | 0 | $0 | 0 | $0 | 1,773,100 | $253,553 |
Yearly summary of insider trading at Gw Pharmaceuticals Plc (GWPH) by Noble James
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | GWPH | 0 | $0 | 82,596 | $1,269,004 | 82,596 | $200,956 |
Yearly summary of insider trading at Curagen Corp (CRGN) by Noble James
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2007 | CRGN | 20,000 | $57,400 | 0 | $0 | 0 | $0 |
Insider trading activities at 3 companies by Noble James:
1. Adaptimmune Therapeutics Plc (ADAP)
2. Gw Pharmaceuticals Plc (GWPH)
3. Curagen Corp (CRGN)
Table 1. Insider trading of Adaptimmune Therapeutics Plc (ADAP) by Noble James
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2020-05-29 | ADAP | Sale | 500,000 | 9.33 | 4,666,000 |
2020-01-13 | ADAP | Sale | 300,000 | 4.50 | 1,350,000 |
2019-05-16 | ADAP | Option Ex | 1,773,100 | .14 | 253,553 |
Table 2. Insider trading of Gw Pharmaceuticals Plc (GWPH) by Noble James
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-05-24 | GWPH | Sale | 82,596 | 15.36 | 1,269,004 |
2019-05-24 | GWPH | Option Ex | 82,596 | 2.43 | 200,956 |
Table 3. Insider trading of Curagen Corp (CRGN) by Noble James
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2007-05-08 | CRGN | Buy | 20,000 | 2.87 | 57,400 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Noble James
(Director of Adaptimmune Therapeutics Plc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.